Influenza virus RNA polymerase with the subunit structure PB1-PB2-PA is involved in both transcription and replication of the RNA genome. By transfection of various combinations of cDNA encoding wild-type and serial deletion mutants of each P protein subunit and co-immunoprecipitation with subunit-specific antibodies, the subunitsubunit contact sites on all three of the P proteins were determined. Results indicate that binary complexes are formed between PB1-PB2 and PB1-PA but not between PB2-PA. Therefore, we concluded that PB 1 is the core subunit for assembly of the virus RNA polymerase. The C-terminal 1 58 amino acids of PB1 bound to the N-terminal 249 amino acids of PB2, while the N-terminal 140 amino acids of PB1 bound to the C-terminal two-thirds of PA. PB2-PA binding was not detected when they were expressed in the absence of the PB1 subunit.
Introduction
Influenza virus has a genome of eight negative-sense ssRNA segments and the virion also contains an RNAdependent RNA polymerase (Lamb, 1989) . Influenza virus RNA polymerase catalyses both transcription [the synthesis of plus-strand mRNA containing a host cell-derived cap1 structure at the 5' terminus and a poly(A) tail at the 3' terminus] and replication (the synthesis of full-length plus-strand cRNA and the cRNA-dependent synthesis of minus-strand vRNA) (Ishihama & Barbier, 1994; Ishihama & Nagata, 1988; Kruget al., 1989) . Besides RNA polymerization, the virus RNA polymerase also performs template-dependent capped RNA cleavage (Kawakami et aI., 1983; Plotch et a] ., 1981) and apparent proof-reading of nascent RNA chains (Ishihama et al., I986)
The RNA polymerase purified from influenza virus consists of one molecule each of three subunits, PB1, PB2 and PA Author for correspondence: Tetsuya Toyoda. Fax +81 942 32 0903. e-mail ttoyoda@ddbj.nig.acjp (Mail to be sent to the Kurume address.) 1 On leave of absence from the Institute of Biochemistry and Physiology, Academy of Science of the Kyrghyz Republic, Kyrghyz Republic. (Honda et al., 1990) . In vitro reconstitution studies of enzymatically active RNA polymerase using individual P proteins purified either from baculovirus expressing P protein cDNAs (Kobayashi eta] ., 1992) or by SDS-PAGE of virions (Szewczyk et aI., 1988) confirmed this subunit structure. The function of each subunit has been genetically and biochemically characterized. For instance, PB1 can be cross-linked with nucleotide substrates (Asano et a] ., 1995; Braam eta] ., 1983) and insect cell nuclear extracts containing PB1 subunit alone are able to catalyse RNA synthesis using synthetic short RNA templates (Kobayashi et al., 1996) . This indicates that PB1 is involved in polymerization of RNA chains. PB2 can be crosslinked in vitro with cap1 analogues (Braam et al., 1983; Ulmanen et al., 1981) and RNA synthesized in vivo in the absence of PB2 lacks the 5' cap structure (Nakagawa et al., 1995) , together suggesting that PB2 is required for capsnatching. The role of PA is not clear yet, but temperaturesensitive (ts) mutations in the PA gene affect vRNA synthesis but not mRNA synthesis (Kruget al., 1975; Mahy et al., 1981; Mowshowitz, 1981; Scholtissek & Bowles, 1975; Scholtissek et al., 1976) .
Recently, transfection systems using reconstituted ribonucleoprotein complexes have been established (Luytjes et aI., 1989; Yamanaka et al., 1991) . These allow identification of the minimum and essential requirements for cis-acting RNA signals (promoters and/or origins recognized by the virus RNA polymerase) and trans-acting protein components (RNA polymerase subunits and NP) for the expression and replication of recombinant RNA genomes. For detailed analysis of the in vivo function(s) of each P protein in transcription and replication, we transfected P protein cDNAs in various combinations. The results were in agreement with the prediction noted above. For instance, transfection of a recombinant genomic RNA into cells expressing PBI, PA and NP (but not PB2) led to the synthesis of virus mRNA that lacked a cap1 structure (Nakagawa eta/., 1995) .
These transfection studies were extended to express mutant P proteins in order to map their functional sites. We describe the subunit-subunit contact sites on each P protein as determined by analysis of series of deletion mutants. Results indicate that PB1 is the core subunit of the RNA polymerase.
Methods
• Cell culture and transfection. COS-7 cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco/BRL) containing 5% fetal bovine serum (FBS; JRC Scientific), 100 U/ml penicillin and 100 ,g/ml streptomycin. Subconfluent cells in 24-well plates were washed three times with Opti-MEM I (Gibco/BRL) and incubated for 6 h in Opti-MEM I containing 4% Lipofectin (Gibco/BRL) and one or combinations of the P protein expression plasmids. After incubation, media were replaced with DMEM containing 5 % FBS and the cells were incubated overnight.
• Construction of epitope-tagged plasmid pCMVcHA, pCMV1 was a gift of M. Stinski (University of Iowa, Ames, Iowa, USA; Andersson eta] ., 1989). pCMVcHA was constructed by inserting a synthetic oligonucleotide duplex composed of 5' CACGCGTTATCC-GTATGATGTGCCCGACTATGCGTAAT 3' and 5' CTAGATTAC-GCATAGTCGGGCACATCATACGGATAACGCGTGGTACGCTG-AT 3' into pCMV1 between the KpnI and XbaI sites (Fig. 1) . pCMVcHA was designed to express fusion proteins with C-terminal haemagglutinin (HA) epitope tags by in-frame insertion at the MluI site.
• Construction of HA-tagged polymerase mutants. A nested set of cDNAs for PB1, PB2 and PA deletion mutants was constructed by PCR amplification using pAPR206 (accession number J02151), pAPR102 (J02152) and pAPR303 (J02153) as templates and synthetic oligonucleotides as primers (Young et a/., 1983) . PCR was carried out using 1 ,g of template and 1,M each of the primers for I5 cycles of denaturation at 94 °C for I min, annealing at 55 °C for 2 min and extension at 72 °C for 3 min, followed by a final extension at 72 °C for 10 min. The amplified fragments except PBIN200, PB1N300, PB1N399 and PBIN500 were digested with KpnI and MluI, purified by agarose gel electrophoresis and inserted into pCMVcHA between the KpnI and MluI sites (Fig. 1) . PBIN200, PBIN300, PBIN399 and PBINS00 were digested with BamHI and MluI, purified by agarose gel electrophoresis and inserted into pCMVcHA between the BglII and M]uI sites. The sequences of PCR-amplified fragments were checked by dideoxynucleotide sequencing using a BcaBEST sequencing kit (Takara).
• Construction of pCMVPB2, pCMVPB1 and pCMVPA. For the construction of expression plasmids for non-tagged wild-type PB1, PB2 and PA (pCMVPB1, pCMVPB2 and pCMVPA), the cloned PCR fragments were isolated after treatment with KpnI and XbaI and inserted into pCMV1 between the KpnI and XbaI sites (Fig. I ).
• Preparation of anti-PB1, anti-PB2 and anti-PA antibodies.
Full-sized PB1, PB2 and PA proteins were expressed in Escherichia coil using the TT-RNA polymerase system (Studier eta/., 1990) . In brief, a SmaI-BamHI adapter (Takara) was inserted into the BamHI site of pET3c to make pET3Sc, cDNA carrying the PB1, PB2 or PA genes of influenza virus A/PR8/34 was cloned from pAPR206, pAPR102 or pAPR303 (Young eta] ., 1983) into pET3Sc at a SmaI site located downstream of the T7 promoter. Using synthetic oligonucleotide primers and PCR, these plasmids were modified so as to express non-fusion proteins (without the phage gene 10 protein). The resulting expression plasmids, pETPB1, pETPB2 and pETPA, were transformed into E. coli BL2I (,~DE3) containing pLysS plasmid. The expression of P proteins was induced by addition of I mM-IPTG (Wako). P proteins were purified by 7% polyacrylamide SDS-PAGE using 491 Prep Cell (Bio-Rad). Antibodies against PB1, PB2 or PA were produced in rabbits.
• Co-immunoprecipitation of the expressed polymerase proteins. In order to determine the contact site with PB2 and PA on the PB1 subunit, 3 ,g of either pCMVPB2 or pCMVPA were co-transfected onto COS-7 cells in 24-well plates with 3 ,g each of either wild4ype (pHAPBlwt) or one of the mutant PB1 expression plasmids (pHAPBIN100, pHAPBIN200, pHAPB1N300, pHAPBIN399, pHAPBINS00, pHAPBIN599, pHAPBIN700, pHAPBIC100, pHAPBIC217, pHAPBIC317, pHAPBIC435, pHAPBIC535 or pHAPBIC617). Likewise, for determination of PB1 and PA contact sites on the PB2 subunit, pCMVPB1 or pCMVPA were co-transfected with wild-type (pHAPB2wt) or one of the mutant PB2 expression plasmids (pHAPB2N104, pHAPB2N205, pHAPB2N304, pHAPB2N401, pHAPB2NS05, pHAPB2N602, pHAPB2C100, pHAPB2C200, pHAPB2C300, pHAPB2C400, pHAPB2CS00 or pHAPB2C600). For determination of PB1 and PB2 contact sites on PA, pCMVPB2 or pCMVPB1 were co-transfected with wild-type (pHAPAwt) or one of the mutant PA expression plasmids (pHAPANI00, pHAPAN200, pHAPAN300, pHAPAN400, pHAPANS00, pHAPAN600, pHAPAC99, pHAPACI99, pHAPAC299, pHAPAC399, pHAPAC499 or pHAPAC599).
After transfection, the cells were pulse-labelled with 1 ,Ci/ml of [3SS]methionine for 0"5, 1, 2, 3, 4 and 6 h in methionine-free MEM. The pulse-labelled cells were washed three times with PBS( --) and lysed with 0-6 ml of TEN(0'5)T buffer (50 mM-Tris-HC[ pH 7"6, 0"5 M-NaC1, I mM-EDTA, 1% Triton X-100 and 1 mM-PMSF; Sigma). After nuclei were removed by centrifugation at 35 000 r.p.m, for 30 min at 4 °C in a TLA-45 rotor (Beckman), the supematant was diluted to 150 mM-NaC1 with TET (50 mM-Tris-HC1 pH 7"6, I mM-EDTA, 1% Triton X-100 and I mM-PMSF; Sigma) and incubated with antibodies against each P protein in the presence of Protein A-agarose (Gibco/BRL) overnight at 4 °C. The antigen-antibody-Protein A complexes were washed three times with the same buffer, resuspended in SDS-sample buffer and subjected to electrophoresis on SDS-polyacrylamide gels (5-15% polyacrylamide gradient or 7"5 % polyacrylamide with 4 M-urea). After staining with Coomassie brilliant blue, the gels were treated with Amplify (NEN) and subjected to fluorography using XAR5 film (Kodak) or directly analysed with an image analyser (BAS2000; Fuji Film).
Results

Expression and formation of RNA polymerase
Expression of a single subunit or combinations of the three subunits of influenza virus RNA polymerase was established 
' , HA-tagged polymerase expression plasmids (pHApol series). Plasmid pCNVcHA was constructed by inserting a synthetic oligonudeotide pair into pCN1V] between the Kpnl and Xbal sites. The inserted oligonucleotide encodes a HA epitope with the indicated amino acid sequence, pHApol plasmids were constructed by insertion of P protein cDNA into pCMVcHA at the Mlul site to express fusion proteins with a C-terminal HA epitope tag (see Methods). Unique restriction sites are indicated in bold.
(b) Non-tagged wild-type P protein expression plasmids (pCMVpol series). PCR-amplified wild-type P protein cDNAs were inserted into pCMVI between the Kpnl and Xbol sites (see Methods). CMV pro, cytomegalovirus immediate early promoter; hGH ter, human growth hormone terminator.
by transfection of PB1, PB2 and/or PA cDNA under the control of the cytomegalovirus promoter (Fig. 1) . The synthesis of each P protein was monitored by immunoprecipitation of radiolabelled proteins with mono-specific antibodies. Using this expression system, we first analysed the formation of RNA polymerase complexes after co-transfection of all three P protein expression plasmids and by immunoprecipitation of radiolabelled P proteins with antibodies against each. Addition of the HA tag did not interfere with subunit assembly. After a 30 min pulse with radioactive methionine, the synthesis of all three P proteins was detected by immunoprecipitation, even though the levels of labelled P proteins were not equal (pre-existing non-radioactive P protein levels were not determined). Both PBI and PB2 were immunoprecipitated by treatment with either anti-PB2 or anti-PB1 antibodies in 30 min pulse (Fig. 2) , and 10 min pulse samples (data not shown). Even after the 30 min pulse, however, radioactive PA was not immunoprecipitated with anti-PB1 or anti-PB2 antibodies. After a 3 h pulse, radioactive PA was coimmunoprecipitated by anti-PBI. These results indicate that the assembly of all three P proteins takes place in the transfected cells using PBI as a core. Thus, the methods employed were found to be useful for the detection of P protein complexes formed in vivo.
Formation of binary P protein complexes
Next, we analysed the formation of binary P protein complexes by co-transfection of two different cDNA plasmids in various combinations. Binary complexes were identified for PB1-PB2 and PB1-PA combinations (Figs 3 and 4) but not for PB2-PA (Fig. 5) . Thus, we concluded that both PB2 and PA bind to PB1, and therefore PB1 is the core subunit in the assembly of influenza virus RNA polymerase, but PB2 and PA do not interact with each other.
Mapping of the subunit-subunit contact sites
The P protein expression system was employed to determine the subunit-subunit contact sites on each P polypeptide. For this purpose, the P protein expression plasmids were modified to express mutant P proteins with various deletions from the N and C termini (Fig. 6 ).
PB1-PB2 contact sites. In order to determine the PBl-binding site on PB2, simultaneous expression of wild-type PB1 and various PB2 mutants with either N-or C-terminal deletions was achieved by co-transfection of wild-type PB1 expression plasmid (pCMVPB1) and the series of expression plasmids for N-terminal deletion mutants (PB2NI04, PB2N205, PB2N304, PB2N401, PB2N505 and PB2N602) or C-terminal deletion mutants (PB2CIO0, PB2C200, PB2C300, PB2C400, PB2C500 and PB2C600). In the 4 h pulse-labelled sample, wild-type PB2 and the C-terminal deletion PB2 mutants, except PB2C600, were co-immunoprecipitated with wild-type PB1 by anti-PB1 antibodies (Fig. 3 a) . None of the N-terminal deletion mutants were co-immunoprecipitated with wild-type PB1, indicating that PB2 binds to PB1 at its N-terminal domain. On the other hand, when immunoprecipitation was carried out by anti-PB2 antibodies, wild-type PB1 was co-precipitated with five species of PB2 C-terminal deletion mutants, PB2CIO0, PB2C200, PB2C300, PB2C400 and PB2CS00 (Fig. 3 c) . Again PB2C600 was not immunoprecipitated, but the expression of PB2C600 might have been below the detection level. Thus we concluded that the PB1 contact site on PB2 is located upstream from residue 249.
Next, the PB2-binding site on the PB1 subunit was determined by co-expression of wild-type PB2 and the series of PB1 N-or C-terminal deletion mutants. The expression or solubility of PB1 deletion mutants in 0"5 M-NaC1 solution was poor when compared with that of PB2 and PA deletion mutants (Fig. 3 b, d ). In the 4 h pulse-labelled sample, wild-type PBI and the N-terminal deletion mutants (PBIN100, PBIN200, PBINd00, PBIN399, PBINS00 and PBIN599) were all coimmunoprecipitated with wild-type PB2 subunit by anti-PB1 antibodies (Fig. 3 b) . When the immunoprecipitation was done with anti-PB2 antibodies, wild-type PB1 and the PB1 Nterminal deletion mutants (PBINI00, PBIN200, PBIN300, PBIN399 and PBINS00) were co-immunoprecipitated. In contrast, the C-terminal deletion mutants (PB 1C 100, PB 1C217, PBIC317, PBIC435 and PBIC535) were not co-immunoprecipitated with PB2 by anti-PB2 antibodies (Fig. 3 d) . The expression of PBIN700 and PBIC617 was not detected. Thus, we concluded that the PB2-binding site on PB1 is located on the C-terminal region downstream from residue 600. PB1-PA contact sites. The PBl-binding site on PA was determined by co-transfection of pCMVPB1 with expression plasmids for the series of PA N-or C-terminal deletion mutants. Labelled PA did not form complexes with wild-type PBI until 2 h of pulse labelling (Fig. 2) . After 3 h of pulse labelling, wild-type PB1 and PBI derivatives became coimmunoprecipitable with PA. Wild-type PA, PAN100 and PAN200 were co-immunoprecipitated with wild-type PB1 by both anti-PB1 and anti-PA antibodies (Fig. 4a, c) . On the other hand, PAC99, PACI99, PAC299, PAC399 and PAC499 were not co-immunoprecipitated with PB1. Thus, we tentatively concluded that the PBl-binding site is located downstream from residue 201. We did not focus further on the PBI-binding site because the expression of PANd00, PAN400, PANSO0, PAN600 and PAC599 was too low to detect immunoprecipitates.
The PA-binding site on PBI was determined by co- expression of wild-type PA and the series of PB1 N-and Cterminal deletion mutants. Again, the expression or solubility of PB1 deletion mutants in 0'5 M-NaC[ solution was poor when compared with that of PB2 and PA (Fig. 4 b, d ). The expression of PBIN300, PBIN599 or PBIN700 was not detected by immunoprecipitation. Wild-type PB1 and all the C-terminal deletion derivatives (PBIC100, PBIC217, PBIC317, PBIC435, PBIC535 and PBIC617) were coimmunoprecipitated with PA by anti-PB1 antibodies (Fig. 4 b) . Wild-type PB1, PBICI00, PBIC217 and PBIC317, on the other hand, were all immunoprecipitated using anti-PA antibodies (Fig. 4 d) . Thus, we concluded that the PA-binding site on PB1 is located upstream from residue 140.
PB2-PA contact sites. The formation of PB2-PA complexes in co-expressing cells was examined by the same procedure as above (Fig. 5) . Both wild-type and mutant PB2 and PA proteins except PAN600, PAC599 and PB2C600 were expressed by simultaneous transfection. However, under the conditions employed (using RIPA buffer or extraction buffers containing 0"5, 0"15, 0"1 or 0"05 M-NaCI) co-immunoprecipitation of these two subunits was not detected by either antibody.
Discussion
Subunit-subunit linkage within the influenza virus RNA polymerase
Prokaryotic RNA polymerase provides a good model of subunit assembly. The RNA polymerase core enzyme of E. coli with a subunit composition of a~fl' is assembled in vitro and in vivo in a sequential manner: ~z --* :% --* a~ --* ~d/fl' (Ishihama, 1981) . Dimerization of the ~ subunit is the first step in this assembly pathway and thus the ~ subunit plays a key role in RNA polymerase formation. The a-a, a-fl and ~-~' contact sites on the :~ subunit were recently identified in the N-terminal assembly domain by deletion, insertion and mutation analysis (Kimura & Ishihama, I995, 1996; ., 1994). Among eukaryotic RNA polymerases, influenza virus RNA polymerase may provide a model for protein-protein assembly and interaction because it consists of three components and each carries a specific and unique function(s). The in vitro assembly systems are not very useful for this purpose at present due to the low solubility of isolated individual P proteins and the low level of reconstitution. . The fragments which were coimmunoprecipitated by only one of these antibodies are indicated by ' +?' and those that were not detected are indicated by ' nd'. The functional map of each subunit is shown above (for details see Fig. 7 ). (ll) Nuclear localization signals (Jones et oL, 1986; IVlukaigawa & Nayak, 1991 ; Nieto et o/., 1994) ; ([~) cap-binding sequences of PB2 (a) (de la Luna et cd., 1989) . The sites of mutations so far determined are indicated by arrowheads (a) (Subbarao eta/., 1993 ; Yamanaka et aL, 1990) . The RNA polymerase consensus motifs of PB1 are indicated as A, B, C and D (b) (Delarue et oL, 1990; Poch et o/., 1989) . (c) The mutation points of ts263 are indicated by arrowheads (Herget & SchoItissek, 1993) and the nucleotide-binding motif of PA (de la Luna et al., 1989) is shown (I). Using the P protein expression system, we demonstrated that binary complexes were formed in vivo between PB1-PB2 and PBI-PA. However, we failed to demonstrate the binding of PB2 and PA. Our observations are consistent with a previous analysis using mRNA injection into Xenopus oocytes (Digard et aI., 1989) . The expressed PB2 and PA were not coimmunoprecipitated in the absence of PB1. However, we cannot exclude direct interaction between PB2 and PA in the assembled three protein complex. In the case of E. coli RNA polymerase, neither a nor fl form stable complexes with be, but ~zfl complex is capable of forming complexes with b e (Ishihama, i98i).
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Subunit-subunit contact sites on each P protein
The results of deletion analysis demonstrated that the PB2 and PA subunits both associate with a single molecule of PB1 but at different domains. The PB2-binding site is located within the C-terminal 158 amino acids while the PA-binding site is located within the N-terminal I40 amino acids (Fig. 7) . P6rez & Donis (I995) mapped the PA-binding site on PB1 within the N-terminal 48 amino acids using a two hybrid system, which is consistent with our results.
From sequence comparisons, PBI is considered to be the catalytic subunit of influenza virus RNA polymerase (Delarue et al., I990; Poch et al., 1989) . In agreement with this prediction, NTPs are specifically cross-linked to the PB1 subunit (Asano et al., I995; Braam et al., 1983) and nuclear extracts containing PBI alone can catalyse RNA synthesis from short RNA templates (Kobayashi et aI., 1996) . The consensus sequence motifs of RNA-dependent RNA polymerases exist in the central portion of PBI protein (Fig. 7) . Therefore, in analogy to the crystallographic structures of T7 RNA polymerase and human immunodeficiency virus reverse transcriptase, the middle part of PB1 is thought to form a structure consisting of ' thumb ', ' fingers' and' palm' domains (Kohlstaedt et al., 1992; Sousa et al., 1993) . It is quite reasonable that the subunitsubunit contact domains are located at both ends of the PB1 molecule, outside the catalytic domain containing the RNA polymerase motifs. The nucleotide-binding site is also located within this catalytic domain (Y. Asano, unpublished results). The nuclear localization signal of PB1 is located in the junction between the two functional domains, upstream of the RNA polymerase motifs but downstream of the PA-binding site. Thus, PB1 can be transported into nuclei even after assembly of PB2 and PA.
The PBl-binding site on PB2 is located in the N-terminal 249 amino acids, while the nuclear localization signals and the cap-binding signals are both located in the C-terminal region (Fig. 7; de la Luna el aI., 1989; Jones et al., 1986; Mukaigawa & Nayak, 1991) . Lawson et al. (1992) isolated ts mutants carrying mutations in the PB2 gene. Some of them mapped to amino acid positions 65, 100, 112 and 174 within the PB1-binding region. These mutations might affect the assembly of RNA polymerase.
The PBl-binding site on PA maps to the C-terminal twothirds (Fig. 7) . Even though fine mapping has not yet been performed, the ts263 mutation of PA, which affects genome replication, has been mapped to this region (amino acid position 671; Herget & Scholtissek, 1993) .
The a subunit of E. coli RNA polymerase plays an key role in the assembly of core enzyme with the subunit structure anti'. Within the N-terminal subunit assembly domain, the fl and fl' subunits bind to the upstream and downstream region, respectively (Igarashi & Ishihama, 1991; Kimura et al., 1994) . Thus, the organization of subunit-subunit contact sites is similar in PB1 of influenza virus RNA polymerase and the a subunit of E. coli RNA polymerase. In the case of E. coli RNA polymerase, the core enzyme subunits are assembled sequentially in the order: :¢ ~ ~2 ~ a~fl --* :~fl'. The mechanism of subunit assembly of influenza virus RNA polymerase is not known but our preliminary observations indicate that it is also assembled sequentially ( Fig. 2; T. Toyoda, unpublished results). Besides the subunit assembly function, the ~ subunit of E. coli RNA polymerase carries the contact domain with trans-acting regulatory proteins and DNA signals. The function of the PB1 subunit is modified from transcriptase in the early phase of virus infection to replicase in the late stage. Involvement of an additional protein factor(s) has been proposed in this conversion (Nagata et al., 1989; Toyoda et al., 1994) . The putative factor for switching may interact with the PB1 subunit.
